These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
3. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
4. Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease. Shively SB; Beltaifa S; Gehrs B; Duong H; Smith J; Edwards NA; Lonser R; Raffeld M; Vortmeyer AO J Pathol; 2008 Dec; 216(4):514-20. PubMed ID: 18836991 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077 [TBL] [Abstract][Full Text] [Related]
6. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease. Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system capillary haemangioblastoma: the pathologist's viewpoint. Hussein MR Int J Exp Pathol; 2007 Oct; 88(5):311-24. PubMed ID: 17877533 [TBL] [Abstract][Full Text] [Related]
8. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms. Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300 [TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619 [TBL] [Abstract][Full Text] [Related]
10. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein. Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425 [TBL] [Abstract][Full Text] [Related]
11. Epididymal cystadenomas and epithelial tumourlets: effects of VHL deficiency on the human epididymis. Gläsker S; Tran MG; Shively SB; Ikejiri B; Lonser RR; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO J Pathol; 2006 Sep; 210(1):32-41. PubMed ID: 16841375 [TBL] [Abstract][Full Text] [Related]
12. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate. Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148 [TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795 [TBL] [Abstract][Full Text] [Related]
16. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
17. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease. Cuesta AM; Albiñana V; Gallardo-Vara E; Recio-Poveda L; de Rojas-P I; de Las Heras KVG; Aguirre DT; Botella LM Sci Rep; 2019 Jul; 9(1):10062. PubMed ID: 31296894 [TBL] [Abstract][Full Text] [Related]
18. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686 [TBL] [Abstract][Full Text] [Related]
19. VHL and PTEN loss coordinate to promote mouse liver vascular lesions. Chen S; Sanford CA; Sun J; Choi V; Van Dyke T; Samulski RJ; Rathmell WK Angiogenesis; 2010 Mar; 13(1):59-69. PubMed ID: 20221685 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma. Wang Y; Abu-Asab MS; Shen D; Zhuang Z; Chew EY; Chan CC Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1319-27. PubMed ID: 24859386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]